Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia

2010 ◽  
Vol 8 (2) ◽  
pp. 98-114 ◽  
Author(s):  
Russ S. Muramatsu ◽  
Mark H.J. Litzinger ◽  
Ed Fisher ◽  
Junji Takeshita
Keyword(s):  
Elderly Patients ◽  
Psychological Symptoms ◽  
Psychotropic Medications ◽  
Delivery Methods ◽  
Behavioral And Psychological Symptoms

Behavioral and psychological symptoms in elderly patients with dementia

2016 ◽  
Vol 108 ◽  
pp. 110
Author(s):  
Jorge J. Llibre-Guerra ◽  
Juan J. Llibre-Rodriguez ◽  
Milagros A. Guerra-Hernández ◽  
Juan C. Llibre-Guerra ◽  
Ana M. Rodriguez-Salgado ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Psychological Symptoms ◽  
Behavioral And Psychological Symptoms

scholarly journals P1-214: Behavioral and Psychological Symptoms in Elderly Patients with Dementia: a 5-Year Cohort Follow Up

2016 ◽  
Vol 12 ◽  
pp. P487-P487
Author(s):  
Erika P. Guartazaca Gerrero ◽  
Jorge J. Llibre Guerra ◽  
Juan C. Llibre ◽  
Milagros A. Guerra Hernández
Keyword(s):  
Elderly Patients ◽  
Psychological Symptoms ◽  
Behavioral And Psychological Symptoms

scholarly journals Management of Behavioral and Psychological Symptoms of Dementia in Elderly Patients with Dementia

2010 ◽  
Vol 6 (3) ◽  
pp. 135-139
Author(s):  
Tatsuya Suzuki ◽  
Jun Norose ◽  
Shoko Futami-Suda ◽  
Kazunari Suzuki ◽  
Kenichi Sekimizu ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Psychological Symptoms ◽  
Behavioral And Psychological Symptoms

scholarly journals Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder

2018 ◽  
Vol 8 (6) ◽  
pp. 284-293 ◽  
Author(s):  
Monica Mathys
Keyword(s):  
Psychological Symptoms ◽  
Psychotropic Medications ◽  
Evidence Based ◽  
Neurocognitive Disorder ◽  
Medication Regimen ◽  
First Line ◽  
Risks And Benefits ◽  
Pharmacologic Management ◽  
Behavioral And Psychological Symptoms ◽  
First Line Treatment

Abstract Behavioral and psychological symptoms of dementia (BPSD) occur in approximately 80% of patients who receive a diagnosis of major neurocognitive disorder. Nonpharmacologic strategies are the first-line treatment for BPSD. However, psychotropic medications are often necessary when nonpharmacologic methods are not effective in treating symptoms that are distressing or are causing behaviors that are dangerous to the patient or the patient's caregivers. The article provides a review of evidence-based recommendations for the use of antipsychotics, cognitive enhancers, and serotonin reuptake inhibitors for the treatment of BPSD. Different pharmacologic approaches are demonstrated through 2 patient cases in which nonpharmacologic management was not effective. The severity of BPSD must be weighed against the risks and benefits of pharmacologic intervention in order to implement an optimal medication regimen.

scholarly journals Acupuncture and Acupressure for Dementia Behavioral and Psychological Symptoms: A Scoping Review

2019 ◽  
Vol 42 (10) ◽  
pp. 867-880 ◽  
Author(s):  
Melissa L. Harris ◽  
Marita G. Titler ◽  
Laura M. Struble
Keyword(s):  
Scoping Review ◽  
Daily Living ◽  
Sleep Disturbances ◽  
Psychological Symptoms ◽  
Psychotropic Medications ◽  
Controlled Trials ◽  
Exclusion Criteria ◽  
Randomized Controlled ◽  
Behavioral And Psychological Symptoms ◽  
Pharmacologic Therapies

Due to the dangers associated with psychotropic medications, there is an urgent need for non-pharmacologic therapies to treat behavioral and psychological symptoms of dementia (BPSD). Acupuncture and acupressure are safe and well-tolerated non-pharmacologic therapies for this population, but currently no review has explored acutherapy for management of distressing dementia symptoms. This review synthesizes research on acupuncture and acupressure for BPSD. Upon searching five databases, 15 studies met inclusion/exclusion criteria. Nine examined acupressure, six acupuncture, and eight were randomized controlled trials. The percent of studies demonstrating statistically significant improvements in symptoms were: activities of daily living (ADLs; 75%), agitation (100%), anxiety (67%), depression (100%), mood (100%), neuropsychological disturbances (67%), and sleep disturbances (100%). Variations in study design, intervention procedures, and outcomes limit interpretations about effectiveness. It is recommended that further research be done to examine the efficacy of these therapies and promote generalizability.

scholarly journals Developing a virtual reality for people with dementia in nursing homes based on their psychological needs: a feasibility study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jung-Hee Kim ◽  
Seonmin Park ◽  
Hyeongji Lim
Keyword(s):  
Virtual Reality ◽  
Nursing Homes ◽  
Intervention Program ◽  
Psychological Symptoms ◽  
Likert Scale ◽  
Psychological Needs ◽  
Second Phase ◽  
People With Dementia ◽  
The Mean ◽  
Behavioral And Psychological Symptoms

Abstract Background The purpose of this study was (1) to develop a virtual reality (VR) intervention program based on the psychological needs of patients residing in nursing facilities in South Korea to alleviate their behavioral and psychological symptoms and (2) to confirm the possibility of utilizing VR in patients with dementia. Methods In the first phase, patients with dementia residing in nursing homes and experiencing behavioral and psychological symptoms were recruited. Surveys and questionnaires were used to identify activities that alleviated the behavioral and psychological symptoms of dementia (BPSD) among the patients. These activities were classified into five types of psychological needs. In the second phase, a fully immersive, interactive, easy-to-use VR platform was developed that reflected these psychological needs. Patients with dementia experienced the VR content. The researchers assessed the level of the participants’ immersion, preference, and interaction with the VR using a 5-point Likert scale. Results In the feasibility test, 10 nursing home residents were recruited. The mean immersion score was 4.93 ± 0.16 points, the mean preference score was 4.35 ± 0.41 points, and the mean interaction score was 3.84 ± 0.43 points using a 5-point Likert scale. Higher mean scores indicated a more positive outcome. Six of the 10 participants required assistance while using the VR. The mean VR experience duration was 10.00 ± 3.46 min. Conclusions The VR-based intervention program that was developed to reduce BPSD was feasible for the participants and provided them with a high degree of satisfaction and immersion. Furthermore, this study also confirmed the convenience and safety of the program. These findings support the potential use of VR-based BPSD intervention programs to treat patients with dementia.

Sign in / Sign up

Export Citation Format

Share Document